penlung-logo

Diagnostic imaging generates thousands of lung related and incidental findings all of which require follow up, tracking and resolution. PenLung has extensive tracking elements for lung imaging including those diagnostic elements introduced by COVID-19.

PenLung also facilitates lung screening (LDCT) programs, tracking outcomes and uploading exam results to the lung cancer screening registry in order to qualify for payment.

To help radiology centers enroll patients in lung screening programs and facilitate tracking of COVID related lung imaging procedures, PenRad is offering PenLung at no charge through December 31, 2020 to new PenLung customers.*

PenLung Features:

• Web-based solution for a quick and easy start
• Tracks lung findings and incidentals, including those related to COVID-19
• ACR LungRADS™ and proposed CORADS
• Patient letters, result, recall/past-due
• Non-conformance tracking
• Facilitates pathology correlation
• Tracking of unresolved cases to resolution
• Statistical audit reporting
• Audit log tracking
• Data mining and analytics
• Registry export and upload

covid19 lung screening

PENRAD OFFERS HOSTED COVID INDUCED LUNG ABNORMALITIES TRACKING SYSTEM FOR NO CHARGE THROUGH DECEMBER 31, 2020

763.475.3388 | Sales@penrad.com

*No charge offer expires July 1, 2020. Includes the features above plus more. At the end of the complimentary use period (December 31, 2020), clients can continue to use PenLung for a nominal fee. Clients may also convert to an onsite solution and purchase workflow efficiency upgrades such as FHIR, email letters, pathology, result/orders interfaces and more.

Contact Us

Have a question? Send us an email!

Not readable? Change text. captcha txt

Start typing and press Enter to search